首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1593504

生物晶片市场规模、份额和成长分析（按类型、製造技术、应用、最终用户、地区）：产业预测（2024-2031）

Biochips Market Size, Share, Growth Analysis, By Type (DNA Chips, Lab-On-A-Chip), By Fabrication Technology (Microarrays, Microfluidics), By Application (Genomics, Drug Development), By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月09日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球生物晶片市场规模估值为95.3亿美元，从2023年的107.4亿美元成长到2031年的279.1亿美元，在预测期间（2024-2031年预计复合年增长率为12.68%，2019年）。

实验室晶片和微阵列（生物晶片）市场正在经历显着的快速增长，这主要是由新型冠状病毒感染疾病（COVID-19）的传播所推动的，扩大了病毒相关诊断和研究对这些技术的需求。我正在实现它。展望未来，由于对 PoC 测试解决方案的需求不断增加、慢性病患病率上升以及蛋白质组学和基因组学在癌症研究中的应用不断扩大，预计该市场将保持其成长轨迹。促成这一市场扩张的关键因素包括主要企业先进诊断测试的开发、全球慢性病负担以及生物晶片在蛋白质组学研究中的越来越多的使用。慢性病是导致残疾和死亡的主要原因，尤其是在老龄化社会中，并且是实验室晶片的系统进行有效诊断的研究和创新的驱动力。此外，生物晶片由于其优点而在生物医学和生物技术领域越来越受欢迎，例如减少样品需求和促进全面蛋白质组分析的能力，这对于生物标记和药物发现工作至关重要。值得注意的是，包括针对 COVID-19的取得专利的诊断检测在内的创新产品的核准对市场动态产生了积极影响，增强了其强劲的成长潜力。随着生物晶片技术和诊断应用的不断进步，这个快速成长的市场将为相关人员提供充足的商机。

市场概况
DNA晶片
- 基因表现
- SNP基因型鉴定
- 癌症诊断/治疗
- 基因组学
- 药物发现
- 农业生物技术
- DNA晶片的其他用途
实验室晶片(LOAC)
- 临床诊断
- 基因组学
- IVD・PoC
- 蛋白质体学
- 药物发现
- 其他实验室晶片应用
蛋白质晶片晶片
- 蛋白质体学
- 表达谱
- 诊断
- 高通量筛检
- 药物发现
- 其他蛋白质晶片应用
其他阵列
- 单元阵列
- 组织阵列

生物晶片市场：依製造技术分类

市场概况
微阵列
微流体

生物晶片市场：依应用分类

市场概况
基因组学
药物开发
农业
其他的

生物晶片市场：依最终用户分类

市场概况
生物技术和製药公司
医院/诊断中心
学术研究所
其他最终用户

生物晶片市场：按地区

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲 (MEA)
- 波湾合作理事会(GCC) 国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Abbott Laboratories
Agilent Technologies, Inc.
PerkinElmer, Inc.
Standard BioTools Inc.
Illumina, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Thermo Fisher Scientific, Inc.
Roche Diagnostics
Micronit Microtechnologies
Randox Laboratories Ltd.
RayBiotech, Inc.
Invitae
CapitalBio Corporation
Genscript Biotech Corp
Takara Bio Usa Holdings, Inc.

简介目录

Product Code: SQMIG45A2235

Global Biochips Market size was valued at USD 9.53 billion in 2022 and is poised to grow from USD 10.74 billion in 2023 to USD 27.91 billion by 2031, growing at a CAGR of 12.68% during the forecast period (2024-2031).

The lab-on-a-chip and microarrays (biochips) market is witnessing a significant surge, largely driven by the COVID-19 pandemic, which amplified the demand for these technologies in diagnostics and research related to the virus. As we move forward, the market is set to continue its growth trajectory, propelled by the increasing demand for point-of-care testing solutions, the rising prevalence of chronic diseases, and the expanding application of proteomics and genomics in cancer research. Key factors contributing to this market expansion include a strong focus on the development of advanced diagnostic tests by leading companies, the global burden of chronic diseases, and the growing utilization of biochips in proteomics studies. Chronic diseases remain a major contributor to disability and mortality rates, particularly among the aging population, driving research and innovation in lab-on-a-chip-based systems for effective diagnosis. Furthermore, biochips are gaining traction within biomedical and biotechnological sectors due to their advantages, such as lower sample requirements and their ability to facilitate comprehensive proteome analyses, crucial for biomarker and drug discovery initiatives. Notably, the approval of innovative products, including patented diagnostic assays for COVID-19, has positively influenced market dynamics, reinforcing its robust growth potential. As the landscape evolves, the ongoing advancements in biochip technology and diagnostic applications are set to create ample opportunities for stakeholders in this burgeoning market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biochips market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biochips Market Segmental Analysis

Global Biochips Market is segmented by Type, Fabrication Technology, Application, End User, and Region. Based on Type, the market is segmented into DNA Chips (Gene Expression, SNP Genotyping, Cancer Diagnosis & Treatment, Genomics, Drug Discovery, Agricultural Biotechnology, Other DNA Chip Applications), Lab-On-A-Chip (Clinical Diagnostics, Genomics, IVD & POC, Proteomics, Drug Discovery, Other Loac Applications), Protein Chips (Proteomics, Expression Profiling, Diagnostics, High-Throughput Screening, Drug Discovery, Other Protein Chip Applications), Other Arrays (Cell Arrays, Tissue Arrays). Based on Fabrication Technology, the market is segmented into Microarrays, Microfluidics. Based on Application, the market is segmented into Genomics, Drug Development, Agriculture, and Others. Based on End User, the market is segmented into Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biochips Market

The ongoing advancements in genomics and proteomics are significant market drivers for the Global Biochips market, as they enable deeper insights into individual genetic profiles and disease mechanisms. The escalating demand for personalized medicine is prompting healthcare providers to seek targeted and tailored medical interventions, where biochips are essential. These devices facilitate the rapid and efficient analysis of vast datasets, allowing for the identification of critical genetic mutations and biomarkers linked to various diseases. Consequently, the enhancement of patient outcomes through personalized treatment plans is propelling the adoption of biochips in clinical settings, further stimulating market growth.

Restraints in the Global Biochips Market

The Global Biochips market faces significant restraints primarily due to the high costs associated with the development and implementation of advanced biochip technologies. Creating accurate and reliable biochips demands substantial financial investment and lengthy development timelines, which can deter potential manufacturers and users alike. Furthermore, integrating these sophisticated devices into existing healthcare systems and laboratory environments often necessitates additional capital outlay for infrastructure upgrades and maintenance. These financial burdens may hinder some healthcare facilities from adopting biochips widely. Nevertheless, as technological innovations continue to emerge and production efficiencies improve, the associated costs are likely to decrease, fostering greater market acceptance over time.

Market Trends of the Global Biochips Market

The Global Biochips market is witnessing a significant trend towards personalized medicine and precision diagnostics, driven by rapid advancements in genomics and proteomics. As healthcare evolves, the demand for customized medical treatments based on individual genetic profiles is intensifying. Biochips, known for their capacity to process large volumes of genetic and protein data, are central to this transformation. Their integration with cutting-edge technologies like artificial intelligence and machine learning enhances the development of advanced diagnostic tools and tailored therapeutic solutions. This trend is facilitating more accurate identification of genetic mutations and disease biomarkers, ultimately fostering improved patient outcomes and driving market growth.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Technology Analysis
Patent Analysis
Regulatory Landscape
PESTEL Analysis

Biochips Market, By Type

Market Overview
DNA Chips
- Gene Expression
- SNP Genotyping
- Cancer Diagnosis & Treatment
- Genomics
- Drug Discovery
- Agricultural Biotechnology
- Other DNA Chip Applications
Lab-On-A-Chip
- Clinical Diagnostics
- Genomics
- IVD & POC
- Proteomics
- Drug Discovery
- Other Loac Applications
Protein Chips
- Proteomics
- Expression Profiling
- Diagnostics
- High-Throughput Screening
- Drug Discovery
- Other Protein Chip Applications
Other Arrays
- Cell Arrays
- Tissue Arrays

Biochips Market, By Fabrication Technology

Market Overview
Microarrays
Microfluidics

Biochips Market, By Application

Market Overview
Genomics
Drug Development
Agriculture
Others

Biochips Market, By End User

Market Overview
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic & Research Institutes
Other End Users

Biochips Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard BioTools Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micronit Microtechnologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RayBiotech, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invitae
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CapitalBio Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript Biotech Corp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Usa Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments